Published in Circulation on June 01, 1970
Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study. J Natl Med Assoc (2002) 1.40
Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart (1999) 1.08
Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia. PLoS One (2013) 0.89
Incidence and significance of coronary artery calcification. Br Heart J (1974) 0.88
Premature cardiac contractions and risk of incident ischemic stroke. J Am Heart Assoc (2012) 0.85
Monophasic action potential of the right atrium in paroxysmal atrial flutter and fibrillation. Br Heart J (1973) 0.84
Paroxysmal atrial flutter and fibrillation. Induction by carotid sinus compression and prevention by atropine. Br Heart J (1972) 0.83
Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch. J Interv Card Electrophysiol (2000) 0.78
Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length. BMC Cardiovasc Disord (2006) 0.75
DDD versus DDDR pacing: effects on the occurrence of atrial arrhythmias and the quality of life in patients with the sick sinus syndrome. Neth Heart J (2002) 0.75
Ablation of atrial fibrillation: a procedure come of age? Curr Control Trials Cardiovasc Med (2001) 0.75
Sinus Node Dysfunction in Atrial Fibrillation: Cause or Effect? J Atr Fibrillation (2008) 0.75
Practolol in treatment of angina pectoris. A double-blind trial. Br Med J (1970) 3.43
A milestone for myocardial infarction. BMJ (1988) 3.42
Results of a general hospital coronary care service. Br Med J (1968) 2.70
Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J (1970) 2.29
Natural history and clinical significance of arrhythmias after acute cardiac infarction. Br Heart J (1967) 2.13
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 2.12
Coronary care for myocardial infarction in diabetics. Lancet (1974) 2.12
Proteinuria with streptokinase. Lancet (1993) 2.01
Cultivar-specific avirulence and virulence functions assigned to avrPphF in Pseudomonas syringae pv. phaseolicola, the cause of bean halo-blight disease. EMBO J (2000) 1.76
Characterization of avrPphE, a gene for cultivar-specific avirulence from Pseudomonas syringae pv. phaseolicola which is physically linked to hrpY, a new hrp gene identified in the halo-blight bacterium. Mol Plant Microbe Interact (1995) 1.37
Sequence variations in alleles of the avirulence gene avrPphE.R2 from Pseudomonas syringae pv. phaseolicola lead to loss of recognition of the AvrPphE protein within bean cells and a gain in cultivar-specific virulence. Mol Microbiol (1998) 1.26
Why do patients develop reactions to streptokinase? Clin Exp Immunol (1993) 1.23
Myocardial infarction in diabetics. Q J Med (1975) 1.22
Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer. Gut (2000) 1.21
The Birmingham blood pressure school study. Postgrad Med J (1983) 1.19
Influence of racial origin on admission rates of patients with suspected myocardial infarction in Birmingham. Br Heart J (1991) 1.17
Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet (1972) 1.17
Intensive care in the management of diabetic ketoacidosis. Lancet (1973) 1.17
Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J (1984) 1.14
Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet (1970) 1.13
Beta-adrenergic blockade in experimental myocardial infarction. Am Heart J (1966) 1.10
Organization of a coronary care unit in a general hospital. Br Med J (1967) 1.08
Changes in systolic time intervals during treatment of diabetes mellitus. Br Heart J (1977) 1.08
Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet (1968) 1.04
Use of low-dose insulin infusions in diabetics after myocardial infarction. Br Med J (Clin Res Ed) (1982) 1.03
The significance of anti-streptokinase antibodies. Clin Exp Immunol (1994) 0.99
Reappraisal of lignocaine therapy in management of myocardial infarction. Br Heart J (1981) 0.99
Report of the task force on the implications for darkly pigmented intact skin in the prediction and prevention of pressure ulcers. Adv Wound Care (1996) 0.96
Intravenous and oral practolol in the acute stages of myocardial infarction. Eur J Cardiol (1978) 0.95
A pregnant patient with Eisenmenger's syndrome. Case report. Br J Anaesth (1971) 0.94
Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus? Diabet Med (1997) 0.93
Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet (1972) 0.93
Myocardial infarct size and mortality in diabetic patients. Br Heart J (1985) 0.93
Modification of the mandibular ramus sagittal split osteotomy. Oral Surg Oral Med Oral Pathol (1987) 0.92
Warning of cardiac arrest due to ventricular fibrillation and tachycardia. Lancet (1972) 0.91
Reversion of ventricular tachycardia by pacemaker stimulation. Br Heart J (1971) 0.88
Suppression of ventricular tachyarrhythmias by transvenous intracardiac pacing after acute myocardial infarction. Br Med J (1970) 0.87
Effect of GL enzyme (a highly purified form of hyaluronidase) on mortality after myocardial infarction. Lancet (1982) 0.86
The distribution of antibodies to streptokinase. Postgrad Med J (1996) 0.86
Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabet Med (1994) 0.85
Massive haematuria associated with sickle-cell trait. Br Med J (1967) 0.85
Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol (1995) 0.84
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers. Br J Clin Pharmacol (1980) 0.83
Lactate and pyruvate metabolism in the exercising ischemic limb. J Clin Invest (1966) 0.82
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings]. Br J Clin Pharmacol (1979) 0.82
Study of infarcted myocardium in cardiac shock. Br Heart J (1970) 0.82
Overt and subclinical reactions to streptokinase in acute myocardial infarction. Am J Cardiol (1994) 0.82
Successful resuscitation in diabetic ketoacidosis: a strong case for the use of bicarbonate. Postgrad Med J (1974) 0.81
The maxillary step osteotomy and Steinmann pin stabilization. J Oral Maxillofac Surg (1985) 0.78
Effects of intrarenal infusions of bradykinin and acetylcholine on renal blood flow in man. Clin Sci (1965) 0.77
Altered expression of the p53-regulated proteins, p21Waf1/Cip1, MDM2, and Bax in ultraviolet-irradiated human skin. Hum Pathol (1998) 0.76
Bradyarrhythmia complicating myocardial infarction. Lancet (1968) 0.76
Electrocardiogram as a guide to potassium replacement in diabetic ketoacidosis. Diabetes (1974) 0.76
Are streptokinase antibodies clinically important? Br Heart J (1994) 0.75
Plasma free fatty acid levels in acute myocardial infarction in diabetic and non-diabetic patients. Br Med J (1975) 0.75
Cyanide self-poisoning. Br Med J (1970) 0.75
Walking through angina. Br Med J (Clin Res Ed) (1985) 0.75
Emergency care in general practice. British Heart Foundation recommends early defibrillation. BMJ (1995) 0.75
Draft definition of stage I pressure ulcers: inclusion of persons with darkly pigmented skin. NPUAP Task Force on Stage I Definition and Darkly Pigmented Skin. Adv Wound Care (1997) 0.75
Association of transient abnormal Q-waves during exercise testing with a stenosis of the main stem of the left coronary artery. Int J Cardiol (1991) 0.75
Serum interleukin 1 beta levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels. Leuk Lymphoma (1994) 0.75
Acute coronary care in the home. Nurs Mirror Midwives J (1975) 0.75
Rehabilitation after myocardial infarction. Physiotherapy (1979) 0.75
Loss of heterozygosity and microsatellite instability at the DCC and nm23 loci in Duke's B colorectal carcinoma. Biochem Soc Trans (1997) 0.75
Coronary care unit or ordinary medical ward? Br Med J (1977) 0.75
Aftercare of acute myocardial infarction. Br J Hosp Med (1978) 0.75
Improvement in prognosis of myocardial infarction by long-term beta-adrenoceptor blockade. Am Heart J (1976) 0.75
Letter: Long-term postinfarction treatment with practolol. Br Med J (1976) 0.75
A controlled trial of GL enzyme in the treatment of acute myocardial infarction. Cardiology (1988) 0.75
Reversion of ventricular tachycardia by pacemaker stimulation. Br Heart J (1972) 0.75
Complications of acute myocardial infarction. Dist Nurs (1970) 0.75
Mortality from myocardial infarction in different types of hospitals. Br Med J (Clin Res Ed) (1987) 0.75
Coronary artery disease. I. Management of the acute episode. Br Med J (1971) 0.75
Fatal myocardial infarction in hypertrophic cardiomyopathy associated with non-penetrating chest trauma. Int J Cardiol (1991) 0.75
Prophylactic lignocaine after myocardial infarction. Lancet (1971) 0.75
Hyaluronidase in the management of myocardial infarction. Int J Cardiol (1982) 0.75
Preventing the second infarct. J R Coll Physicians Lond (1980) 0.75
Pattern of onset and cessation of atrial fibrillation in man. Br Heart J (1970) 0.75
Part-time work in specialist medicine. Summary and recommendations of a report of a working party of the Royal College of Physicians. J R Coll Physicians Lond (1994) 0.75
The Birmingham Trial of permanent pacing in patients with intraventricular conduction disorders after acute myocardial infarction. Am Heart J (1984) 0.75
Eisenmenger's complex with widespread thrombotic manifestations. Am Heart J (1968) 0.75
Cardiac rehabilitation: does it do any good? Br J Hosp Med (1992) 0.75
Olefin complexes of divalent ruthenium formed by chelating olefinic tertiary phosphines and arsines. Inorg Chem (1974) 0.75
Synthesis, structure, and reactions of binuclear gold(I) complexes containing two different bridging ligands. Inorg Chem (2001) 0.75